# A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection

> **NCT04991688** · PHASE2 · TERMINATED · sponsor: **University Hospital, Bordeaux** · enrollment: 11 (actual)

## Conditions studied

- Low Anterior Resection Syndrome (LARS>20)
- Refractory Medical Treatment After Rectal Resection

## Interventions

- **DRUG:** BOTOX-A

## Key facts

- **NCT ID:** NCT04991688
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-01-07
- **Final completion:** 2023-03-03
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Organizational difficulties
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04991688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04991688, "A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04991688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*